Evelo Biosciences Financials

Evelo Biosciences Stock Summary

Evelo Biosciences competes with Aileron Therapeutics, ABVC Biopharma, Surrozen, Processa Pharmaceuticals, and Tempest Therapeutics. Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Evelo Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.

Evelo Biosciences Key Financial Ratios

Evelo Biosciences' financial ratios allow both analysts and investors to convert raw data from Evelo Biosciences' financial statements into concise, actionable information that can be used to evaluate the performance of Evelo Biosciences over time and compare it to other companies across industries.

Evelo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Evelo Biosciences's current stock value. Our valuation model uses many indicators to compare Evelo Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evelo Biosciences competition to find correlations between indicators driving Evelo Biosciences's intrinsic value. More Info.Evelo Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Evelo Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Evelo Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Evelo Biosciences Market Pulse

Along with financial statement analysis, the daily predictive indicators of Evelo Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Evelo Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Evelo Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Evelo Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Evelo Biosciences's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

If you are still planning to invest in Evelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evelo Biosciences' history and understand the potential risks before investing.